CYTO
Price
$0.46
Change
+$0.05 (+12.20%)
Updated
Nov 14, 03:19 PM (EDT)
SPHDF
Price
$11.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CYTO vs SPHDF

Header iconCYTO vs SPHDF Comparison
Open Charts CYTO vs SPHDFBanner chart's image
Altamira Therapeutics
Price$0.46
Change+$0.05 (+12.20%)
Volume$200
CapitalizationN/A
Santhera Pharmaceuticals Holdings
Price$11.70
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
CYTO vs SPHDF Comparison Chart
Loading...
CYTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CYTO vs. SPHDF commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTO is a Hold and SPHDF is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CYTO: $0.41 vs. SPHDF: $11.70)
Brand notoriety: CYTO and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTO: 160% vs. SPHDF: 100%
Market capitalization -- CYTO: $1.74M vs. SPHDF: $115.5M
CYTO [@Biotechnology] is valued at $1.74M. SPHDF’s [@Biotechnology] market capitalization is $115.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTO’s FA Score shows that 1 FA rating(s) are green whileSPHDF’s FA Score has 0 green FA rating(s).

  • CYTO’s FA Score: 1 green, 4 red.
  • SPHDF’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTO is a better buy in the long-term than SPHDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTO’s TA Score shows that 5 TA indicator(s) are bullish.

  • CYTO’s TA Score: 5 bullish, 3 bearish.

Price Growth

CYTO (@Biotechnology) experienced а -17.89% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.82%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.12%.

Reported Earning Dates

CYTO is expected to report earnings on Nov 17, 2022.

Industries' Descriptions

@Biotechnology (-0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPHDF($116M) has a higher market cap than CYTO($1.74M). SPHDF YTD gains are higher at: 0.000 vs. CYTO (-88.086).
CYTOSPHDFCYTO / SPHDF
Capitalization1.74M116M1%
EBITDA-6.12MN/A-
Gain YTD-88.0860.000-
P/E Ratio0.23N/A-
Revenue0N/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CYTO vs SPHDF: Fundamental Ratings
CYTO
SPHDF
OUTLOOK RATING
1..100
440
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9570
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
45n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTO's Valuation (10) in the Biotechnology industry is somewhat better than the same rating for SPHDF (68) in the null industry. This means that CYTO’s stock grew somewhat faster than SPHDF’s over the last 12 months.

CYTO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SPHDF (100) in the null industry. This means that CYTO’s stock grew similarly to SPHDF’s over the last 12 months.

CYTO's SMR Rating (100) in the Biotechnology industry is in the same range as SPHDF (100) in the null industry. This means that CYTO’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (70) in the null industry is in the same range as CYTO (95) in the Biotechnology industry. This means that SPHDF’s stock grew similarly to CYTO’s over the last 12 months.

CYTO's P/E Growth Rating (92) in the Biotechnology industry is in the same range as SPHDF (100) in the null industry. This means that CYTO’s stock grew similarly to SPHDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTO
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCB73.661.15
+1.59%
Coastal Financial Corp
ORI37.480.04
+0.11%
Old Republic International Corp
CMTL2.53-0.01
-0.39%
Comtech Telecommunications Corp
BCAN8.00-0.20
-2.44%
Femto Technologies Inc
AMBA58.21-1.50
-2.51%
Ambarella

CYTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTO has been loosely correlated with CMND. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTO jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTO
1D Price
Change %
CYTO100%
-9.87%
CMND - CYTO
36%
Loosely correlated
-3.92%
SPHDF - CYTO
35%
Loosely correlated
N/A
LOGC - CYTO
32%
Poorly correlated
-3.02%
COGT - CYTO
30%
Poorly correlated
+0.19%
UBX - CYTO
30%
Poorly correlated
-0.76%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+0.61%
COGT - SPHDF
63%
Loosely correlated
+0.19%
MEOBF - SPHDF
50%
Loosely correlated
-0.72%
KROS - SPHDF
38%
Loosely correlated
-2.79%
CYTO - SPHDF
35%
Loosely correlated
-9.87%
More